Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients

被引:0
|
作者
Nadir Alpay
Abdullah Ozkok
Yasar Caliskan
Tulin Akagun
Suzan Adın Cinar
Gunnur Deniz
Muzaffer Sariyar
Alaattin Yildiz
机构
[1] Istanbul University,Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul School of Medicine
[2] Istanbul Medeniyet University,Department of Internal Medicine and Nephrology, Goztepe Training and Research Hospital
[3] Istanbul University,Experimental Medical Research Institute
[4] Medicana International Hospital,undefined
来源
关键词
Everolimus; Calcineurin inhibitors; Monocyte chemoattractant protein; Neutrophil gelatinase-associated lipocalin; Pulse wave velocity; Transforming growth factor-β;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:961 / 967
页数:6
相关论文
共 50 条
  • [31] Proteinuria following switch from calcineurin inhibitors to sirolimus in renal transplant patients
    Colak, Turan
    Gorur, Sarp K.
    Karakayali, Hamdi
    Haberal, Mehmet
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 273 - 274
  • [32] Randomized Controlled Trial of Early Conversion from Calcineurin Inhibitor to Everolimus in Adult Renal Allograft Patients at a Single Transplant Center in Mexico
    Noyola-Villalobos, H.
    Martinez-Calva, I
    Gomez Vazquez, A.
    Mendiola Fernandez, R.
    Jimenez Chavarria, E.
    Rendon Dosal, H.
    Ide Castaneda, P.
    Espinoza, F.
    Mendoza Camacho, V
    [J]. TRANSPLANTATION, 2012, 94 (10) : 910 - 910
  • [33] Improvement of Renal Function After the Switch from a Calcineurin Inhibitor to Everolimus in Liver Transplant Recipients with Chronic Renal Dysfunction
    Castroagudin, Javier F.
    Molina, Esther
    Romero, Rafael
    Otero, Esteban
    Tome, Santiago
    Varo, Evaristo
    [J]. LIVER TRANSPLANTATION, 2009, 15 (12) : 1792 - 1797
  • [34] Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction
    Fischereder, M.
    Graeb, C.
    Krueger, B.
    Kammerl, M. C.
    Zuelke, C.
    Jauch, K. W.
    Kraemer, B. K.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (05) : 1295 - 1297
  • [35] Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: A multicenter study
    Ruiz, JC
    Diekmann, F
    Campistol, JM
    Sanchez-Fructuoso, A
    Rivera, C
    Oliver, J
    Fernandez-Fresnedo, G
    Arias, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3833 - 3835
  • [36] Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Interstitial Fibrosis and Tubular Atrophy.
    Gupta, G.
    Kumar, D.
    Raynaud, M.
    Loupy, A.
    Chang, J.
    Reeve, J.
    Sanghi, P.
    Yakubu, I.
    Kamal, L.
    Levy, M.
    Bhati, C.
    Kimball, P.
    King, A.
    Massey, H.
    Halloran, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 451 - 452
  • [37] The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors
    Lam, P
    Yoshida, A
    Brown, K
    Abouljoud, M
    Bajjoka, I
    Dagher, F
    Moonka, DK
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) : 1029 - 1035
  • [38] The Efficacy and Limitations of Sirolimus Conversion in Liver Transplant Patients Who Develop Renal Dysfunction on Calcineurin Inhibitors
    Patrick Lam
    Atsushi Yoshida
    Kimberly Brown
    Marwan Abouljoud
    Iman Bajjoka
    Fadi Dagher
    Dilip K. Moonka
    [J]. Digestive Diseases and Sciences, 2004, 49 : 1029 - 1035
  • [39] Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomised study of everolimus vs. calcineurin inhibitors
    Villamil, Federico G.
    Gadano, Adrian C.
    Zingale, Fernanda
    Perez, Roberto
    Gil, Octavio
    Yantorno, Silvina
    Mastai, Ricardo
    Cairo, Fernando O.
    Otero, Alcira B.
    Dong, Gaohong
    Lopez, Patricia
    [J]. LIVER INTERNATIONAL, 2014, 34 (10) : 1513 - 1521
  • [40] Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study
    Budde, Klemens
    Rath, Thomas
    Sommerer, Claudia
    Haller, Hermann
    Reinke, Petra
    Witzke, Oliver
    Suwelack, Barbara
    Baeumer, Daniel
    May, Christoph
    Porstner, Martina
    Arns, Wolfgang
    [J]. CLINICAL NEPHROLOGY, 2015, 83 (01) : 11 - 21